Numares Health Expands into ASEAN with First Regulatory Approval in Malaysia
Germany-based numares Health has taken a key step in its global expansion strategy by entering the ASEAN region.
The company has received regulatory approval in Malaysia for its AXINON® LDLp Test System and secured its first regional contract with BioD Medica.
A First for AXINON® in ASEAN
This approval marks the first regulatory clearance for the AXINON® LDLp Test System in Southeast Asia.
BioD Medica will support market entry across Malaysia and Singapore, leveraging its experience in medical device adoption and healthcare technology rollout.
Why This Matters for Cardiovascular Care?
Cardiovascular diseases remain the leading cause of death worldwide, according to the World Health Organization.
Traditional lipid panels measure total cholesterol, LDL, HDL, and triglycerides, but they often miss deeper risk signals.
AXINON® LDLp goes further by analyzing:
LDL particle concentration
Particle size
Particle distribution
These insights help identify hidden cardiovascular risk, especially in patients with multiple comorbidities.
A Shift Toward Precision Diagnostics
LDL particles are the actual carriers of cholesterol in the bloodstream. By directly measuring LDL-p, AXINON® enables more accurate risk stratification than standard lipid profiles.
This can support earlier interventions and more personalized treatment decisions for high-risk patients.
Strengthening numares’ Global Footprint
With regulatory approval secured and a commercial partner in place, numares is positioning itself for broader adoption across ASEAN. The move reinforces the company’s focus on advanced metabolomics-based diagnostics that translate complex data into practical clinical decisions.
As cardiovascular risk continues to rise globally, tools that deliver clearer insights will play an increasingly central role in patient care.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!